BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Steven S. Carroll, Steven Ludmerer, Larry Handt, Kenneth Koeplinger, Nanyan Rena Zhang, Donald Graham, Mary-Ellen Davies, Malcolm MacCoss, Daria Hazuda, David B. Olsen. Robust Antiviral Efficacy upon Administration of a Nucleoside Analog to Hepatitis C Virus-Infected ChimpanzeesAntimicrobial Agents and Chemotherapy 2009; 53(3): 926 doi: 10.1128/AAC.01032-08
2
T. Li, Y. Xu, S. Yin, B. Liu, S. Zhu, W. Wang, Y. Wang, F. Liu, J.-P. Allain, C. Li. Characterization of major histocompatibility complex class I allele polymorphisms in common marmosetsTissue Antigens 2014; 84(6): 568 doi: 10.1111/tan.12453
3
Tomoko Chiyo, Satoshi Sekiguchi, Masahiro Hayashi, Yoshimi Tobita, Yumi Kanegae, Izumu Saito, Michinori Kohara. Conditional gene expression in hepatitis C virus transgenic mice without induction of severe liver injury using a non-inflammatory Cre-expressing adenovirusVirus Research 2011; 160(1-2): 89 doi: 10.1016/j.virusres.2011.05.019
4
Xuan Guo, Jin-Yi Zhong, Jun-Wen Li. Hepatitis C Virus Infection and Vaccine DevelopmentJournal of Clinical and Experimental Hepatology 2018; 8(2): 195 doi: 10.1016/j.jceh.2018.02.003
5
Jayme E. Locke, Michael J. Shamblott, Andrew M. Cameron. Stem Cells and the Liver: Clinical Applications in TransplantationAdvances in Surgery 2009; 43(1): 35 doi: 10.1016/j.yasu.2009.03.002
6
Daniel P Webster, Paul Klenerman, Jane Collier, Katie JM Jeffery. Development of novel treatments for hepatitis CThe Lancet Infectious Diseases 2009; 9(2): 108 doi: 10.1016/S1473-3099(09)70020-9
7
JEEYOUNG KIM, HUIJEONG AHN, HEUNG-MYONG WOO, EUNSONG LEE, GEUN-SHIK LEE. Generation of liver-specific TGF-α and c-Myc-overexpressing fibroblasts for future creation of a liver cancer porcine modelMolecular Medicine Reports 2014; 10(1): 329 doi: 10.3892/mmr.2014.2217
8
Ryota Kikuchi, Matthew McCown, Pamela Olson, Chise Tateno, Yoshio Morikawa, Yumiko Katoh, David L. Bourdet, Mario Monshouwer, Adrian J. Fretland. Effect of Hepatitis C Virus Infection on the mRNA Expression of Drug Transporters and Cytochrome P450 Enzymes in Chimeric Mice with Humanized LiverDrug Metabolism and Disposition 2010; 38(11): 1954 doi: 10.1124/dmd.109.031732
9
Lezlee Coghlan. Handbook of Laboratory Animal Science, Volume III, Third Edition2013; : 219 doi: 10.1201/b16317-9
10
Jian Jiao, Jiangbin Wang, Matii Sallberg. Effects of HCV proteins in current HCV transgenic modelsHepatology Research 2010; 40(2): 115 doi: 10.1111/j.1872-034X.2009.00574.x
11
Wen-Ta Hu, Hui-Chun Li, Shen-Kao Lee, Hsin-Chieh Ma, Chee-Hing Yang, Hung-Ling Chen, Shih-Yen Lo. Both core and F proteins of hepatitis C virus could enhance cell proliferation in transgenic miceBiochemical and Biophysical Research Communications 2013; 435(1): 147 doi: 10.1016/j.bbrc.2013.04.059
12
Martijn WH Leenders, Maarten W Nijkamp, Inne HM Borel Rinkes. Mouse models in liver cancer research: A review of current literatureWorld Journal of Gastroenterology 2008; 14(45): 6915-6923 doi: 10.3748/wjg.14.6915
13
Markus von Schaewen, Qiang Ding, Alexander Ploss. Visualizing hepatitis C virus infection in humanized miceJournal of Immunological Methods 2014; 410: 50 doi: 10.1016/j.jim.2014.03.006
14
Markus von Schaewen, Jenna M. Gaska, Alexander Ploss. Hepatitis C Virus I2016; : 275 doi: 10.1007/978-4-431-56098-2_12
15
Martina Smolic, Catherine H Wu, Shilpa Madadi, Nidhi Gupta, Robert Smolic, Marcy Coash, Jeanette Smith, George Y Wu. Pharmacogenetic selection of transplanted human hepatocytes in immunocompetent ratsJournal of Digestive Diseases 2012; 13(11): 579 doi: 10.1111/j.1751-2980.2012.00632.x
16
Helène Gilgenkrantz. HepatocytesMethods in Molecular Biology 2010; 640: 475 doi: 10.1007/978-1-60761-688-7_26
17
Jarrod Bailey. An Assessment of the Use of Chimpanzees in Hepatitis C Research Past, Present and Future: 1. Validity of the Chimpanzee ModelAlternatives to Laboratory Animals 2010; 38(5): 387 doi: 10.1177/026119291003800501
18
J. Jo, V. Lohmann, R. Bartenschlager, R. Thimme. Experimental models to study the immunobiology of hepatitis C virusJournal of General Virology 2011; 92(3): 477 doi: 10.1099/vir.0.027987-0
19
Hirofumi Akari, Yuki Iwasaki, Tomoyuki Yoshida, Sayuki Iijima. Non-human primate surrogate model of hepatitis C virus infectionMicrobiology and Immunology 2009; 53(1): 53 doi: 10.1111/j.1348-0421.2008.00087.x
20
Y. Wang, S. Mao, B. Li, P. Tan, D. Feng, J. Wen. Treatment of hepatitis C virus core-positive hepatocytes with the transfer of recombinant caspase-3 using the 2',5'-oligoadenylate synthetase gene promoterActa Biochimica et Biophysica Sinica 2009; 41(7): 554 doi: 10.1093/abbs/gmp044
21
Eva Billerbeck, Ype de Jong, Marcus Dorner, Cynthia de la Fuente, Alexander Ploss. Hepatitis C Virus: From Molecular Virology to Antiviral TherapyCurrent Topics in Microbiology and Immunology 2013; 369: 49 doi: 10.1007/978-3-642-27340-7_3
22
Heidi Barth, Eric Robinet, T. Jake Liang, Thomas F. Baumert. Mouse models for the study of HCV infection and virus–host interactionsJournal of Hepatology 2008; 49(1): 134 doi: 10.1016/j.jhep.2008.03.012
23
Andre Boonstra, Luc J. W. van der Laan, Thomas Vanwolleghem, Harry L. A. Janssen. Experimental models for hepatitis C viral infectionHepatology 2009; 50(5): 1646 doi: 10.1002/hep.23138
24
Madiha Khalid, Sobia Manzoor, Muhammad Imran, Muqddas Tariq, Javed Ashraf, Qazi Laeeque Ahmed, Waseem Ashraf, Fahed Parvaiz, Muhammad Ashraf. Development of murine models to study Hepatitis C virus induced liver pathogenesisIndian Journal of Virology 2013; 24(2): 151 doi: 10.1007/s13337-013-0152-1
25
Ying Xu, Sheng-Xiang Lv. The effect of JAK2 knockout on inhibition of liver tumor growth by inducing apoptosis, autophagy and anti-proliferation via STATs and PI3K/AKT signaling pathwaysBiomedicine & Pharmacotherapy 2016; 84: 1202 doi: 10.1016/j.biopha.2016.09.040
26
Alexander Ploss, Amit Kapoor. Animal Models of Hepatitis C Virus InfectionCold Spring Harbor Perspectives in Medicine 2020; 10(5): a036970 doi: 10.1101/cshperspect.a036970
27
Yan Liu, Christoph Meyer, Chengfu Xu, Honglei Weng, Claus Hellerbrand, Peter ten Dijke, Steven Dooley. Animal models of chronic liver diseasesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2013; 304(5): G449 doi: 10.1152/ajpgi.00199.2012
28
Xiaoyong Zhang, Anke Kraft, Ruth Broering, Joerg F Schlaak, Ulf Dittmer, Mengji Lu. Preclinical development of TLR ligands as drugs for the treatment of chronic viral infectionsExpert Opinion on Drug Discovery 2012; 7(7): 597 doi: 10.1517/17460441.2012.689281
29
Faezeh Ghasemi, Sina Rostami, Zahra Meshkat. Progress in the development of vaccines for hepatitis C virus infectionWorld Journal of Gastroenterology 2015; 21(42): 11984-12002 doi: 10.3748/wjg.v21.i42.11984